ISSUE NO. 1
Ontario spent this week reminding us that not all square footage is created equal.
Toronto opened a $925-million vaccine plant. Marathon moved a $410-million mineral-processing facility closer to construction. And in Brampton, one of the province’s best-known factories is still looking for a future.
One is open. One is planned. One is a very large question mark.
Let’s get into it.
THE BRIEF
A $925-million vaccine plant opens in Toronto
Sanofi has opened a 263,000-square-foot vaccine manufacturing facility at its Connaught Campus in North York.
The facility will manufacture, fill and package Fluzone High-Dose, an influenza vaccine for adults aged 65 and older. It is expected to create 300 skilled jobs and received $55 million in provincial support.
Sanofi’s recent Ontario investments now exceed $2 billion across three projects.
Marathon moves closer to a $410-million processing facility
Generation Mining has secured up to $11 million in conditional provincial support for a proposed copper-palladium processing facility.
The facility is part of a larger $992-million project expected to support approximately 800 construction jobs and more than 450 permanent positions.
Ontario does not just want minerals taken out of the ground here. It wants more of the valuable processing to happen here too.
Brampton has an extremely large real-estate problem
Stellantis is reportedly discussing the sale of its idled Brampton assembly plant to Canadian armoured-vehicle manufacturer Roshel.
The federal government has warned that public funding could be clawed back if auto production does not resume. Roshel says a deal could put more than 2,000 people back to work.
The building, highway connections and industrial history are already there.
None of that guarantees the property a future. A factory without a viable operator is still an extremely large real-estate problem.
THE LEAD
The building matters. What it makes matters more.
Toronto and Marathon are 1,200 kilometres apart, but their new facilities have more in common than the distance suggests.
One will make vaccines. The other will process copper and palladium.
Both are expensive, specialized and difficult to relocate. Both have government support. And both produce something governments have decided Ontario should not depend entirely on others to supply.
That matters for real estate.
These operations cannot be dropped into ordinary industrial buildings. Power, labour, infrastructure, approvals and access to the right supply chain matter as much as the structures themselves.
Brampton shows the other side of the equation.
Its assembly plant is large, well located and carries decades of industrial history. But yesterday’s strategic property does not automatically remain tomorrow’s strategic property.
Someone still needs a viable reason to operate it.
The next phase of Ontario’s industrial market will not be won by whoever has the most square footage. It will be won by sites equipped for the industries actually attracting capital.
The building matters. What the building makes matters more.
DEAL SHEET
Ottawa
Sienna Senior Living has agreed to acquire Stonemont On the Park, a 305-suite retirement residence, for approximately $170.7 million.
The property opened in 2024 and is approximately 99% occupied. The price works out to roughly $560,000 per suite, before a possible $10-million earnout.
Expensive? Yes. But so is creating 305 new suites, leasing nearly all of them and building an operating platform around them.
Markham: 165 Commerce Valley Drive West traded for $25.7 million—approximately $306 per square foot.
Kitchener: 1604 Victoria Street North traded for $20 million—approximately $239 per square foot.
Cambridge: 900 Maple Grove Road traded for $13.8 million—approximately $255 per square foot.
The read: Nearly $60 million changed hands across these three properties, with pricing ranging from $239 to $306 per square foot.
Transactions reported by Altus Group →
DEVELOPMENTS & DECISIONS
No, Ontario construction did not collapse by 68.8%
Ontario building permits fell 68.8% in July.
Before anyone declares a construction collapse, June’s numbers were inflated by one enormous medical permit.
Total industrial, commercial and institutional permits reached $2.17 billion in July—much closer to the province’s recent norm. Commercial construction represented just over half of the total.
Toronto remained the largest permit market. Brantford was the surprise, jumping from $10.1 million in June to $136.4 million in July.
The lesson: provincial numbers tell us the direction of the market, but one large project can make them look drunk.
THE NUMBER
$560,000
That is approximately what Sienna is paying for each suite at Stonemont On the Park.
Nobody pays that price because they love the carpeting.
The property is new, approximately 99% occupied and operating in a sector supported by an aging population and limited new supply.
Sienna is paying for the income already in place—and the difficulty of reproducing it.
THE BOTTOM LINE
Money is moving through Ontario commercial real estate, but it is becoming much more selective about where it lands.
This week’s winners all had something difficult to reproduce: specialized infrastructure, strategic importance, strong occupancy or durable demand.
A generic building with a vague business plan will have a harder time.
A property that solves a real problem—where to manufacture vaccines, process minerals or house an aging population—can still attract serious capital.
That distinction is becoming the market.
That’s it for Issue No. 1.
What project, transaction or local decision should we be watching? Reply and send it my way.
The best stories usually begin with someone saying, “Have you seen this?”
See you next Thursday,
Gary Paul
Publisher, The Ontario Commercial Brief
ocbrief.ca